avelumab
merck,pfizer
['urothelial carcinoma', 'avelumab', 'urothelial']
 phase ib study of avelumab and novel axl inhibitor avb-s6-500 in patients with metastatic urothelial carcinoma (muc) #asco22 
#PsyOnc @CettroOncologia | Former Postdoc Fellow & Visiting Scholar @cityofhope | @IPOSPsychoOncol BOD 2021-2023 | #ASCO22 FCOI: https://t.co/wuOhYiJHBM